SG10201914001QA - Modulation of macrophage activation - Google Patents

Modulation of macrophage activation

Info

Publication number
SG10201914001QA
SG10201914001QA SG10201914001QA SG10201914001QA SG10201914001QA SG 10201914001Q A SG10201914001Q A SG 10201914001QA SG 10201914001Q A SG10201914001Q A SG 10201914001QA SG 10201914001Q A SG10201914001Q A SG 10201914001QA SG 10201914001Q A SG10201914001Q A SG 10201914001QA
Authority
SG
Singapore
Prior art keywords
modulation
macrophage activation
macrophage
activation
Prior art date
Application number
SG10201914001QA
Inventor
E Ting Anthony
W Mays Robert
A Hamilton Jason
A Busch Sarah
Silver Jerry
Original Assignee
Abt Holding Co
Univ Case Western Reserve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abt Holding Co, Univ Case Western Reserve filed Critical Abt Holding Co
Publication of SG10201914001QA publication Critical patent/SG10201914001QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0607Non-embryonic pluripotent stem cells, e.g. MASC
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201914001QA 2010-02-25 2011-02-24 Modulation of macrophage activation SG10201914001QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30808210P 2010-02-25 2010-02-25
US31664710P 2010-03-23 2010-03-23

Publications (1)

Publication Number Publication Date
SG10201914001QA true SG10201914001QA (en) 2020-03-30

Family

ID=44507208

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10201914001QA SG10201914001QA (en) 2010-02-25 2011-02-24 Modulation of macrophage activation
SG10201907877YA SG10201907877YA (en) 2010-02-25 2011-02-24 Modulation of macrophage activation
SG10201501402UA SG10201501402UA (en) 2010-02-25 2011-02-24 Modulation of macrophage activation
SG2012063186A SG183497A1 (en) 2010-02-25 2011-02-24 Modulation of macrophage activation

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG10201907877YA SG10201907877YA (en) 2010-02-25 2011-02-24 Modulation of macrophage activation
SG10201501402UA SG10201501402UA (en) 2010-02-25 2011-02-24 Modulation of macrophage activation
SG2012063186A SG183497A1 (en) 2010-02-25 2011-02-24 Modulation of macrophage activation

Country Status (7)

Country Link
US (1) US20110305638A1 (en)
EP (2) EP2539436B1 (en)
AU (1) AU2011220721B2 (en)
DK (1) DK2539436T3 (en)
IL (2) IL282662B2 (en)
SG (4) SG10201914001QA (en)
WO (1) WO2011106521A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2245141B1 (en) 2008-01-18 2018-03-14 Regents of the University of Minnesota Stem cell aggregates and methods for making and using
SG193847A1 (en) * 2008-09-04 2013-10-30 Abt Holding Co Use of stem cells to prevent neuronal dieback
SG10201503700WA (en) * 2010-05-12 2015-06-29 Abt Holding Co Modulation of splenocytes in cell therapy
EP2639313A1 (en) * 2012-03-14 2013-09-18 Rheinische Friedrich-Wilhelms-Universität Bonn High-resolution transcriptome of human macrophages
SG11201508403XA (en) 2013-04-12 2015-11-27 Saverio Lafrancesca Improving organs for transplantation
CN108025024B (en) 2015-07-28 2022-11-29 宾夕法尼亚大学董事会 Modified monocytes/macrophages expressing chimeric antigen receptors and uses thereof
AU2016387339B2 (en) 2016-01-21 2022-11-17 Abt Holding Company Stem cells for wound healing
CN106929474B (en) * 2017-03-31 2021-09-14 北京恒峰铭成生物科技有限公司 M2 macrophage inducer
IL297438A (en) * 2020-04-23 2022-12-01 Abt Holding Co Treatment of virus-induced acute respiratory distress syndrome
BR112022024228A2 (en) 2020-06-04 2023-02-07 Carisma Therapeutics Inc CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
US4749620A (en) 1984-02-15 1988-06-07 Massachusetts Institute Of Technology Encapsulated active material system
JPH0628570B2 (en) 1986-02-13 1994-04-20 雪印乳業株式会社 Method and device for manufacturing capsule body
EP0301777A1 (en) 1987-07-28 1989-02-01 Queen's University At Kingston Multiple membrane microencapsulation
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
EP0435928A1 (en) 1988-09-21 1991-07-10 Animal Biotechnology Cambridge Limited Derivation of pluripotential embryonic cell lines from domestic animals
US5089272A (en) 1989-03-29 1992-02-18 Snow Brand Milk Products Co., Ltd. Process for producing capsules having a permeability-controllable membrane
US7037721B1 (en) 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
GB2254289B (en) 1991-04-05 1995-03-22 Gerber Garment Technology Inc Readily transferrable adherent tape and methods of use and making
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
WO1993009220A1 (en) 1991-11-06 1993-05-13 Correa Paulo N Cell culture medium
US5578442A (en) 1992-03-23 1996-11-26 Vivorx, Inc. Graft copolymers of polycationic species and water-soluble polymers, and use therefor
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5340740A (en) 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
US5564183A (en) 1992-09-30 1996-10-15 Matsushita Electric Industrial Co., Ltd. Producing system of printed circuit board and method therefor
US7153684B1 (en) 1992-10-08 2006-12-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5766951A (en) 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US5766948A (en) 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
EP0802800B1 (en) 1993-08-12 2002-06-12 Neurotech S.A. Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules
US6037174A (en) 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
US6432711B1 (en) 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
FR2726003B1 (en) 1994-10-21 2002-10-18 Agronomique Inst Nat Rech CULTURE MEDIUM OF AVIAN TOTIPOTENT EMBRYONIC CELLS, METHOD FOR CULTURING THESE CELLS, AND AVIAN TOTIPOTENT EMBRYONIC CELLS
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5914268A (en) 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5837670A (en) 1995-04-18 1998-11-17 Hartshorn; Richard Timothy Detergent compositions having suds suppressing properties
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US6015554A (en) 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US6190910B1 (en) 1996-05-21 2001-02-20 The Institute Of Physical And Chemical Research Mouse embryonic stem cell lines
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6361996B1 (en) 1997-05-07 2002-03-26 University Of Utah Research Foundation Neuroepithelial stem cells and glial-restricted intermediate precursors
WO1998059035A2 (en) 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
WO1999001159A1 (en) 1997-07-04 1999-01-14 University Of Utah Research Foundation Lineage-restricted neuronal precursors
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
WO2000027995A1 (en) 1998-11-09 2000-05-18 Monash University Embryonic stem cells
EP1131407B1 (en) 1998-11-09 2006-10-11 Consorzio per la Gestione del Centro di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US8075881B2 (en) * 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
WO2001098463A1 (en) 2000-06-20 2001-12-27 Es Cell International Pte Ltd Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists
US7560280B2 (en) 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
EP1367899A4 (en) 2001-02-14 2004-07-28 Leo T Furcht Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
RU2291703C2 (en) 2001-08-23 2007-01-20 Релайанс Лайф Сайенсиз Пвт., Лтд Isolation of inner cell mass to produce human embryonic stem cell lines
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US6703279B2 (en) 2002-01-04 2004-03-09 Promos Technologies, Inc. Semiconductor device having contact of Si-Ge combined with cobalt silicide
BRPI0307074A2 (en) 2002-01-25 2017-06-20 Genzyme Corp serum free chondrocyte media and methods for its use
US7145057B2 (en) 2002-02-01 2006-12-05 Origen Therapeutics, Inc. Chimeric bird from embryonic stem cells
AU2003230695A1 (en) 2002-03-20 2003-10-08 Sara Griffin Sports training device
GB0221481D0 (en) 2002-09-16 2002-10-23 Richards John M Grip for hand held instruments
US20060210544A1 (en) * 2003-06-27 2006-09-21 Renomedix Institute, Inc. Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
EP3461884A1 (en) * 2004-03-22 2019-04-03 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US7670596B2 (en) * 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
PL1981515T3 (en) * 2006-01-23 2014-02-28 Athersys Inc Mapc treatment of brain injuries and diseases
WO2008057469A1 (en) * 2006-11-02 2008-05-15 Wyeth Small organic molecule regulators of cell proliferation
WO2009134429A2 (en) * 2008-05-02 2009-11-05 Massachusetts Institute Of Technology Methods and compositions for modulating immunological tolerance
US20090298102A1 (en) * 2008-05-09 2009-12-03 Rich Ivan N Cell Potency Assay
SG193847A1 (en) * 2008-09-04 2013-10-30 Abt Holding Co Use of stem cells to prevent neuronal dieback
US20130129686A1 (en) * 2009-11-19 2013-05-23 Regents Of The University Reducing Inflammation Using Cell Therapy
US20160069903A1 (en) * 2014-09-10 2016-03-10 Fundació Institute De Ciències Foròniques Method for detecting cells

Also Published As

Publication number Publication date
EP2539436B1 (en) 2021-09-22
AU2011220721A1 (en) 2012-09-20
DK2539436T3 (en) 2021-10-18
SG10201907877YA (en) 2019-09-27
SG10201501402UA (en) 2015-04-29
EP3940060A1 (en) 2022-01-19
US20110305638A1 (en) 2011-12-15
EP2539436A4 (en) 2013-08-14
IL282662B1 (en) 2023-09-01
EP2539436A1 (en) 2013-01-02
WO2011106521A1 (en) 2011-09-01
IL265832A (en) 2019-06-30
SG183497A1 (en) 2012-09-27
IL282662A (en) 2021-06-30
IL265832B (en) 2022-05-01
AU2011220721B2 (en) 2015-02-05
IL282662B2 (en) 2024-01-01

Similar Documents

Publication Publication Date Title
HUS1900001I1 (en) Modulation of transthyretin expression
HK1200032A1 (en) Modulation of macrophage activation
IL282662A (en) Modulation of macrophage activation
GB2478005B (en) Enhanced spatial modulation
EP2595664A4 (en) Modulation of nuclear-retained rna
EP2564610A4 (en) Dynamic frequency refarming
EP2493061A4 (en) Converter
EP2626107A4 (en) Applicator
EP2580985A4 (en) Head-hair treatment-agent applicator
EP2864479A4 (en) Modulation of ube3a-ats expression
EP2776564A4 (en) Modulation of tmprss6 expression
EP2588183A4 (en) Antiseptic applicator assembly
IL270957A (en) Modulation of angiogenesis
GB201000448D0 (en) Indirect pairing
EP2566513A4 (en) Gfi1b modulation and uses thereof
EP2524296A4 (en) Extending view functionality of application
EP2600339A4 (en) Converter
EP2539356A4 (en) Modulation of smad3 expression
EP2623577A4 (en) Adhesive
GB201001130D0 (en) Ts2
GB201020224D0 (en) Catalyst activator
GB201018904D0 (en) Applicator
HU1000688D0 (en) Use of trifluoro-phal